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ABSTRACT 
Solid dispersions are most promising system to increase the solubility of poorly water soluble drugs.  By using reduction in drug particle size in 
required specification, and due to that improving drug wettability, bioavailability may be todays need. Solid dispersion generally presented as 
amorphous products, mainly obtained by two major different methods, melting and solvent evaporation. Now days, surfactants have been 
included to stabilize the formulations, thus avoiding drug recrystallization and potentiating their solubility. New manufacturing processes to 
obtain solid dispersions have also been developed to reduce the drawbacks of the initial process. In this review, it is intended to discuss the 
consideration during formulation development also role of hydrophobic polymer for solubility enhancement various strategy to inhibit the 
recrystallization. 
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Generally there are various routes for administration of 
drugs but most of time oral route is preferential for the 
administration of drug because of the patient convenience. 
Also taking a medicine by swallowing the drug which is easy 
for the patient. However in oral route various obstacles are 
get involve i.e. low absorption of poorly water soluble drug 
that directly affect the bioavailability of drug.1 
Solid dispersion is the technique which is used to establish or 
to increase the solubility and improve the bioavailability of 
the drug which eventually increases the rate of dissolution in 
the aqueous media. In an amorphous solid dispersion (ASD), 
the solubility of the drug substance is improved by 
disrupting its crystalline lattice to produce a higher energy 
amorphous form. Compared with other enabling 
solubilization approaches, an ASD can hold a much higher 
dose for low-solubility active pharmaceutical ingredients 
(APIs). ASDs improve bioavailability by maintaining 
supersaturation in the gastrointestinal (GI) tract. While 
supersaturation is sustained, the absorption of a compound 
can be maximized to be greater than that of a saturated 
solution.5 In addition, the solubility differences amongst 
crystalline physical forms (e.g., polymorphs) are eliminated 
because they are converted to the amorphous form. This is 
predominantly advantageous for compounds in the research 
stage when the form is not clearly distinct. ASDs are usually 
well tolerated in animal disease models and are acceptable to 
toxicologists as their polymer carriers are derived from 
GRAS (generally regarded as safe) excipients. Commonly 
used excipients for forming ASDs are cellulose derivatives 
such as hydroxypropyl methylcellulose 
(HPMC), hypromellose acetate succinate (HPMCAS), 
hydroxypropyl methylcellulose phthalate (HPMCP), hydroxy 
ethyl cellulose, hydroxypropyl cellulose (HPC), cellulose 
acetate phthalate (CAP), methyl cellulose, carboxymethyl 
cellulose, ethyl cellulose, carboxymethyl ethyl cellulose, 
chitosan, cyclodextrin and derivatives, lactose, poloxamers, 
polyvinylpyrrolidone (PVP), polyvinylpyrrolidone-vinyl 
acetate copolymer (PVP/VA 64), polyvinyl acetate phthalate 
(PVAP), polymethacrylates (Eudragit E, L, S, FS), and 
polyethylene glycols (PEG) derivatives.These polymers are 
biologically inert and minimally absorbed.6 
Most of the research of solid dispersion involves the class 2 
drugs i.e. having poorly water soluble and highly permeable 
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to biological membrane. Hence, hypothesis has been that the, 
rate of absorption will in vivo increase with an increase rate 
of dissolution. So according to BCS classification, poorly 
water soluble and highly permeable drugs are promising 
factor in solid dispersion technology for BCS class 2 drugs.2  
Now a days lots of research use natural polymer for 
improving the solubility and bioavailability of the drug. 
Generally natural polymer used are in the modified form for 
ex., Guar gum, xanthan gum, hupu gum, locust bean gum  
which is modified form of natural polymer. Some of the 
natural polymer having less ability to enhance the solubility 
of poorly water soluble drugs due its high viscosity and their 
hygroscopic nature. Herbal drug technologies have the drug 
utilization of phytoconstituents and bioactive contents in 
precise manner. In natural product research there is 
rekindling of discoveries of noval molecule. But there is 
limited therapeutic potential due to low solubility, 
bioavailability and instability associated with herbal. 
Exploration of solid dispersion provides various advantages 
including enhancement of solubility and bioavailability, 
protection from toxicity enhancement of stability, sustained 
release, protection from physical and chemical degradation 
etc.2,3 
Solid dispersion is more suitable approach as compared to 
chemical approach for improving the solubility and 
bioavailability of drug. Salt formation is limited approach. 
For example, it is applicable only to the weakly acidic and 
basic drug and not applicable to neutral drug. In case of 
prodrug approach parent drug must have specific chemical 
groups like hydroxyl, carboxylic, amide etc otherwise it can’t 
be converted into prodrug. Formulation approach involves 
particle size, size reduction, lipid base, solid dispersion, 
formation of molecular complex, pH adjustment, 
solubilization.  Solid dispersion technique are more effective 
technique in particle size reduction with concomitant 
improvement in drug release as compared to micronization 
or milling  process in which limited particle size up to 2 to 
5µm. this is insufficient to improve the drug absorption in 
the small intestine. However the handling of more 
amorphous powder is very difficult due to their low 
mechanical properties like low flow, high adhsion and 
hygroscopic nature etc. solid dispersion are generally 
prepared by three different methods : 1) solid fusion method 
2) fusion melt method and 3) hybrid-fusion method. Hence 
there is high potential for some important drugs should be 
formulated into solid dispersion which subsequently 
provides safe effective and convenient delivery of bioactive 
constituents in effective and controlled manner. 
In 1995 amidon classified active pharmaceutical ingredients 
into four groups on the basis of their solubility and 
permeability called as biopharmaceutical classification 
system. These systems involve mathematical analysis to 
experimentally determine solubility and permeability of 
drugs under specified conditions. According to the USFDA i.e. 
food and drug administration, a drug is considered to be 
highly soluble when its highest clinical dose strength is 
soluble in <250 ml of aqueous media at pH range 1- 7.5 at 
37.5 ºC. and if absorption of orally administered dose I 
humans is 90% then it is considered to be highly permeable. 
 
 
Selection of carriers for Preparation4: 
The choices of carrier have tremendous impact on solid 
dispersion. Following criteria should be considered during 
selection of carrier 
 It should have High water solubility: it improves the 
wettability and enhance dissolution. 
 Hugh glass transition time: it improves stability  
 Minimal water uptake  
 It should be soluble in common solvent with Drug-
Solvent evaporation. 
 It should have relatively low melting point: for melting 
process. 
 It should be capable of forming solid solution with the 
drug. 
 Particles should have higher porosity which influences 
carrier properties and increases the drug release 
profile.  
 Drug should be in amorphous state which leads to 
enhancement in drug release and requires low energy 
as compare to crystalline state of drug. 
 There should be conversion of liquid dosage form into 
solid form. 
Limitations4: 
 Moisture and temperature can affect the physical 
mixture of solid dispersion. 
 Sometimes tackiness property of solid dispersion 
makes it difficult to handle. 
 Large amount of carrier require achieving better 
dissolution. 
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 Many problems encountered during storage of solid 
dispersion such as phase separation, conversion of 
amorphous to crystalline form and due to crystal 
growth there is decrease in solubility. 
 Method of preparation is expensive. 
Classification1: 
The type of solid dispersion and its dissolution behavior are 
strongly influenced by physicochemical properties of drug 
and carrier and the used production process. 
 
 
Sr.No. Types of  SD Matrix  Drug  Remark  No of 
phases 
1 Eutectics  C C First type of SD  2 
2 Amorphous precipitations 
in crystal matrix  
C A Rarely encountered  2 
3 Continuous 
 


























Miscible at all composition, never prepared  
 
Partially miscible  
 
Molecular diameter of drug should be 5% differ from the 
carrier diameter. In that case drug and matrix are 
substitutional, can be continuous or discontinuous. 
 
Can be discontinuous only because molecular diameter of 





1 or 2 
4 Glass suspension  A C Particle size of solid dipsersion  is related or depends on 
rate of cooling and evaporation  . Obtained after 
crystallization of drug in amorphous matrix  
 
2 
5 Glass suspension A A Particle size of dispersed phase dependent on 
cooling/evaporation rate many solid dispersions are of 









it requires  miscibility or  solid solubility, complex 
formation or upon fast cooling or evaporation during 





Method of preparation for Solid Dispersion7: 
1. Solvent evaporation method  
2. Melting / Fusion method  
3. Kneading Technique  
4. Co-precipitation method  
5. Co-grinding method  
6. Gel entrapment technique  
7. Spray-Drying Method  
8. Electro spinning  
9. Freeze-drying 
10. Supercritical fluid method  
11. Melt Agglomeration Process  
12. Lyophilisation Technique  
13. Dropping method solution  
14. Melt Extrusion Method  
1. Solvent evaporation method: 
In this method, the physical mixture of the drug and carrier 
is dissolved in a common solvent, which is evaporated until a 
clear, solvent free film is left. The film is further dried to 
constant weight. The main advantage of the solvent method 
is thermal decomposition of drugs or carriers can be 
prevented because of the relatively low temperatures 
required for the evaporation of organic solvents. However, 
some disadvantages are associated with this method such as  
1) The higher cost of preparation. 
2) The difficulty in completely removing liquid solvent. 
3) The possible adverse effect of traces of the solvent on 
the chemical stability. 
4) The selection of a common volatile solvent. 
5) The difficulty of reproducing crystal form. 
6) In addition, a super saturation of the solute in the solid 
system cannot be attained except in a System showing 
highly viscous properties. 
Modified solvent evaporation method:  
Drug is dissolved in organic solvent at its saturation 
solubility with continuous stirring for some time. Polymer is 
suspended in sufficient amount of water (up to wet mass of 
polymer). The drug solution is poured at once into polymer 
suspension. The entire solvent is evaporated. The mass 
obtained is dried.  
2. Melting /Fusion method: 
This method involves the preparation of physical mixture of 
a drug and a water soluble carrier and heating it directly 
until it melted. The melted mixture is then solidified rapidly 
in an ice-bath under vigorous stirring. The final solid mass is 
crushed, pulverized and sieved. The modification in the 
method can be done by pouring the homogenous melt in the 
form of a thin layer onto a ferrite plate or a stainless steel 
plate and cooled by flowing air or water on the opposite side 
of the plate. In addition, a super-saturation of a solute or 
drug in a system can often be obtained by quenching the 
melt rapidly from a high temperature. Under such 
conditions, the solute molecule is arrested in the solvent 
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matrix by the instantaneous solidification process. The 
quenching technique gives a much finer dispersion of 
crystallites when used for simple eutectic mixtures.  
Advantage of melting method is that, it is economic and 
solvent less process, however this method is not suitable for 
the drug or carrier which is unstable at fusion temperature 
or evaporates at higher temperature. Some of the means to 
overcome these problems could be by heating the physical 
mixture in a sealed container or melting it under vacuum or 
in presence of inert gas like nitrogen to prevent oxidative 
degradation of drug or carrier.  
3. Kneading Technique:  
In this method, carrier is permeated with water and 
transformed to paste. Drug is then added and kneaded for 
particular time. The kneaded mixture is then dried and 
passed through sieve if necessary.  
4. Co-precipitation method:  
Required amount of drug is added to the solution of carrier. 
The system is kept under magnetic agitation and protected 
from the light. The formed precipitate is separated by 
vacuum filtration and dried at room temperature in order to 
avoid the loss of the structure water from the inclusion 
complex. 
5. Co-grinding method:  
Physical mixture of drug and carrier is mixed for some time 
employing a blender at a particular speed. The mixture is 
then charged into the chamber of a vibration ball mill steel 
balls are added. The powder mixture is pulverized. Then the 
sample is collected and kept at room temperature in a screw 
capped glass vial until use. Ex. chlordiazepoxide and 
mannitol solid dispersion was prepared by this method.  
6. Gel entrapment technique:  
Hydroxyl propyl methyl cellulose is dissolved in organic 
solvent to form a clear and transparent gel. Then drug for 
example is dissolved in gel by sonication for few minutes. 
Organic solvent is evaporated under vacuum. Solid 
dispersions are reduced in size by mortar and sieved.  
7. Spray-Drying Method:  
Drug is dissolved in suitable solvent and the required 
amount of carrier is dissolved in water. Solutions are then 
mixed by sonication or other suitable method to produce a 
clear solution, which is then spray dried using spray dryer.  
8. Electro spinning:  
Electro spinning is a process in which solid fibers are 
produced from a polymeric fluid stream solution or melt 
delivered through a millimeter-scale nozzle. This process 
involves the application of a strong electrostatic field over a 
conductive capillary attaching to a reservoir containing a 
polymer solution or melt and a conductive collection screen. 
Upon increasing the electrostatic field strength up to but not 
exceeding a critical value, charge species accumulated on the 
surface of a pendant drop destabilize the hemispherical 
shape into a conical shape (commonly known as Taylor s 
cone). Beyond the critical value, a charged polymer jet is 
ejected from the apex of the cone (as a way of relieving the 
charge built-up on the surface of the pendant drop). The 
ejected charged jet is then carried to the collection screen 
via the electrostatic force. The Columbic repulsion force is 
responsible for the thinning of the charged jet during its 
trajectory to the collection screen. The thinning down of the 
charged jet is limited If the viscosity increases, the charged 
jet is dried. This technique has tremendous potential for the 
preparation of nanofibres and controlling the release of 
biomedicine, as it is simplest, the cheapest this technique 
can be utilized for the preparation of solid dispersions in 
future.  
9. Freeze-drying:  
This process consists of dissolving the drug and carrier in a 
common solvent, which is immersed in liquid nitrogen until 
it is fully frozen. Then, the frozen solution is further 
lyophilized. Although it is concluded in literature that this is 
a promising and suitable technique to incorporate drug 
substances in stabilizing matrices, the technique is poorly 
exploited for the preparation of solid dispersions. An 
important advantage of freeze drying is that, the drug is 
subjected to minimal thermal stress during the formation of 
the solid dispersion. However, the most important 
advantage of freeze drying is that the risk of phase 
separation is minimized as soon as the solution is vitrified.  
10. Supercritical fluid method:  
Supercritical fluid methods are mostly applied with carbon 
dioxide (CO2), which is used as either a solvent for drug and 
matrix or as an anti-solvent. This technique consists of 
dissolving the drug and the carrier in a common solvent that 
is introduced into a particle formation vessel through a 
nozzle, simultaneously with CO2. When the solution is 
sprayed, the solvent is rapidly extracted by the SCF, resulting 
in the precipitation of solid dispersion particles on the walls 
and bottom of the vessel. The use of processes using SCF 
reduces particle size, residual solvent content, without any 
degradation and often results in high yield.  
11. Melt Agglomeration Process:  
The utility of the surfactant systems in solubilisation is very 
important. Adsorption of surfactant on solid surface can 
modify their hydrophobicity, surface charge, and other key 
properties that govern interfacial processes such as 
flocculation/dispersion, floatation, wetting, solubilisation, 
detergency, and enhanced oil recovery and corrosion 
inhibition. Surfactants have been reported to cause 
solvation/plasticization, manifesting in reduction of melting 
the active pharmaceutical ingredients, glass transition 
temperature and the combined glass transition temperature 
of solid dispersions. Because of these unique properties, 
surfactants have attracted the attention of investigators for 
preparation of solid dispersions.  
12. Lyophilisation Technique:  
Lyophilisation involves transfer of heat and mass to and 
from the product under preparation. This technique was 
proposed as an alternative technique to solvent evaporation. 
Lyophilisation has been thought of a molecular mixing 
technique where the drug and carrier are co-dissolved in a 
common solvent, frozen and sublimed to obtain a lyophilized 
molecular dispersion.  
13. Dropping method solution:  
The dropping method, developed by to facilitate the 
crystallization of different chemicals, is a new procedure for 
producing round particles from melted solid dispersions. 
This technique may overcome some of the difficulties 
inherent in the other methods. For laboratory-scale 
preparation, a solid dispersion of a melted drug-carrier 
mixture is pipette and then dropped onto a plate, where it 
solidifies into round particles. The use of carriers that 
solidify at room temperature may aid the dropping process. 
The dropping method not only simplifies the manufacturing 
process, but also gives a higher dissolution rate. It does not 
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use organic solvents and, therefore, has none of the 
problems associated with solvent evaporation.  
14. Melt Extrusion Method:  
Solid dispersion by this method is composed of active 
ingredient and carrier, prepared by hot stage extrusion 
using a co-rotating twin-screw extruder. The concentration 
of drug in the dispersions is always 40% (w/w). Melt 
extrusion technique is used in the preparation of diverse 
dosage forms in the pharmaceutical industry e.g. sustained-
release pellet.  
Effect of hydrophillic and hydrophobic polymer on 
the dissolution of drug: 
In recent years there are number of research are carried out, 
(hai van ngo, toi wei duan, et al.) in this study they used 
blend of hydrophilic and hydrophobic polymer which both 
play an important role in influence of dissolution rate of 
Isradipine while hydrophobic polymer (zein) play both role 
in inhibition of crystal growth and also helps to increase the 
dissolution rate. Hydrophobic polymer helps to change the 
crytal structure into amorphous form that ultimately affect 
the particle size i.e. reduction in particle size increases the 
surface area of the particle which helps to increase the rate 
of dissolution.8 
Hydrophobic polymers are soluble in organic solvents and 
practically insoluble in aqueous media, from this study they 
conclude that both blend of hydrophilic and hydrophobic 
polymers play important role in modulation of crystalline 
changes and also they are fairly compatible with each other. 
Blend of hydrophilic and hydrophobic polymer is recent 
technique which can be used in the solid dispersion for 
increase the dissolution rate of drug. 
Hydrophilic polymers are a major area of polymer research 
with prominent fields of application, e.g., in drug delivery11, 
self-assembly12,13, or catalysis14. As such, studies regarding 
hydrophilic polymers are an important part of polymer 
science. Especially investigations on structure-property 
relationships of hydrophilic polymers as well as interactions 
of hydrophilic polymers or the combination with biological 
entities are a key research area15,16. Here, synthetic polymer 
chemistry opens up new opportunities via novel water-
soluble polymer types, architectures or combinations for 
advanced properties and future applications. Hydrophilic 
polymers not only feature significant properties in the 
dissolved state, but also as cross-linked materials, namely in 
hydrogels. This class of materials presents various 
interesting properties and tailored shape and size, which is 
of major interest for biomedical applications as well.16,17  
Strategy to avoid recrystallization: 
Recrystallization is the main disadvantage of solid 
dispersions. while amorphous systems, they are 
thermodynamically unstable and have the tendency to 
change to a more stable state under recrystallization.  
Molecular mobility is a key factor leading the stability of 
amorphous phases18, because even at very high viscosity, 
below the glass transition temperature (Tg), there is 
sufficient mobility for an amorphous system to crystallize 
over pharmaceutically relevant time scales,19,20 In addition, 
it was postulated that crystallization above Tg would be 
governed by the configurational entropy, because this was a 
measure of the probability of molecules being in the suitable 
conformation, and by the mobility, because this was related 
to the number of collisions per unit time. 
A number of experiments have been carried out to 
understand the stabilization of solid dispersions. current 
studies observed very small reorientation motions in solid 
dispersions showing a detailed heterogeneity of solid 
dispersions and finding  the sub-glass transition beta-
relaxation as well as alpha-relaxation21, which may lead to 
nucleation and crystal growth21. Molecular mobility of the 
amorphous system depends, not only on its composition, but 
also on the manufacturing process as declared by Bhugra et 
al30. Solid dispersions exhibit high conformational entropy 
and lower molecular mobility are more physically stable19.  
Polymers improve the physical stability of amorphous drugs 
in solid dispersions by increasing the Tg of the miscible 
mixture, so reducing the molecular mobility at regular 
storage temperatures, or by interacting specifically with 
functional groups of the drugs20,23. Meant for a polymer to be 
effective in preventing crystallization, it has to be 
molecularly miscible with the drug24,25. For complete 
miscibility, interactions between the two components are 
necessary. It is predictable that the majority of drugs contain 
hydrogen-bonding sites21, therefore, several studies have 
shown the formation of ion–dipole interactions and 
intermolecular hydrogen bonding between drugs and 
polymers, and the interruption of the hydrogen bonding 
pattern quality to the drug crystalline structure23 These lead 
to a higher miscibility and physical stability of the solid 
dispersions25,26,27Specific drug polymer interactions were 
observed by Teberekidis et al28, showing that interaction 
energies, electron density, and vibrational data revealed a 
stronger hydrogen bond of felodipine with PVP than with 
PEG, which was in agreement with the dissolution rates of 
the corresponding solid dispersions. 
Further studies have shown stabilization in systems where 
hydrogen- bonding interactions are not possible, because of 
the chemistry of the system 28. Vippagunta et al27 concluded 
that fenofibrate does not exhibit specific interactions with 
PEG, independent of the number of hydrogen bonds 
donating groups presented27. The same conclusion was 
achieved by Weuts et al.29 in the preparation of solid 
dispersions of loperamide with PVP K30 and PVP VA64, in 
which, hydrogen bonds were no absolute condition to avoid 
crystallization. 
Considerations during Dissolution 
The vehicle composition of formulation is important. Tween 
80 at a concentration of 0.2%–0.5% is usually used as a 
wetting agent in suspensions of crystalline material. though, 
it reduced the drug release and led to precipitation in a short 
period of time in the case of an LCQ789 ASD suspension,48 
which is consistent with the authors’ observations with 
other research compounds (unpublished data). In another 
study, Tween 80 at a concentration of 10% was added in an 
ASD suspension. Formulation because it provided significant 
solubility improvement for the neat crystalline compound. It 
was likely that Tween 80 would act like parachute to delay 
precipitation from the supersaturated solution of ASD. 
Astonishingly, the solid dispersion crystallized after 3 h in 
the media with Tween 80, whereas it was stable for more 
than 6 h when Tween 80 was not present.31 
When an ASD is dosed at low concentrations, suspending 
agents, such as methylcellulose, may need to be added.5 
though, when ASD is dosed at high concentrations, water or 
buffer without suspending agent may be used as the amount 
of polymer released from the ASD can provide as a 
suspension agent. Water was selected to suspend the 
LCQ789 ASD, which facilitated formulations of 10, 50, and 
120 mg/mL of ASD.32 When the compound is pH sensitive or 
the polymer solubility is pH dependent, the pH of the 
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suspension vehicle and the buffer composition should be 
carefully selected. The preparation should avoid energetic 
mixing as it can accelerate reversion to a crystalline form. 
The powder can be effectively wetted first by adding a 
minimal amount of suspension vehicle and stirring gently 
with a spatula. 
The dissolution temperature of an ASD formulation is 
important too. It should be set close to physiological 
temperature. Although equilibrium solubility increases with 
elevated temperature and the solubility difference between 
25°C and 37°C is usually minimal,33,34 the solubility of a neat 
amorphous compound or ASD may decrease with increased 
medium temperature because crystallization onset may be 
earlier, crystallization rate may be faster, amorphous 
material agglomerates may be more extensive, and 
crystalline precipitation from supersaturation may also 
occur sooner.35 Therefore, dissolution at a biologically 
relevant temperature is necessary for ASD-based 
formulations, whereas dissolution at room temperature can 
be acceptable for dosage forms containing crystalline 
phases. 
Conclusion 
As from this review, it is comprehensible that the solid 
dispersion technology is one of the advanced approaches to 
determine the problem of solubility of poorly water-soluble 
drugs. So, proceeding to developing a new solid dispersion 
system for a given drug, it is essential to examine the physio-
chemical properties of the drug and carrier that can best fit 
with each other. Also, the method of preparation and the 
ratio of carrier to drug also play a vital role in the 
solubility/dissolution rate enhancement of drug. We have 
attempted in bringing all the things in progression in this 
article that how to furnish all these aspects to achieve this 
goal. So in the novel drug delivery applications, solid 
dispersion technology will continue to develop in future and 
solve problems associated with the delivery of poorly water 
soluble drugs.  
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